chr1:11166592:> Detail (hg19) (MTOR)

Information

Genome

Assembly Position
hg19 chr1:11,166,592-11,322,564
hg38 chr1:11,106,535-11,262,507 

HGVS

Type Transcript Protein
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

[No Data.]

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
bladder carcinoma Everolimus,Pazopanib C Predictive Supports Sensitivity/Response Somatic 3 24625776 Detail
melanoma B Prognostic Supports Poor Outcome Somatic 3 26490311 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
A case-study of a patient with urothelial carcinoma reported exceptional response (14 months) in a p... CIViC Evidence Detail
Median overall survival of patients with nonsynonymous mutations in mTOR was shorter. CIViC Evidence Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
Genome
hg19
Position
chr1:11,166,592-11,322,564
Variant Type
snv
Variant (CIViC) (CIViC Variant)
MUTATION
Transcript 1 (CIViC Variant)
ENST00000361445.4
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/277
Genome browser